<?xml version="1.0" encoding="iso-8859-1"?><?xml-stylesheet href="http://www.congoo.com/css/rss.css" type="text/css" media="screen"?><rss version="2.0"><channel><title>Cancer News - Congoo</title><link>http://www.congoo.com/feed/newschannelsfeed.aspx?chid=69&amp;catid=262</link><description>News Feed for - Cancer</description><item><title>Celebrating 25 Years and Counting: Leukemia and Lymphoma Society's "Team In Training" </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239724312&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:33:00</pubDate><description>-TNT Fuels 300 New Research Programs to Discover Breakthrough Treatments&amp; Cures- PR Newswire  WHITE PLAINS, N.Y., June 19, 2013 WHITE PLAINS, N.Y., June 19, 2013 /PRNewswire/ --? This year alone, The </description><source>Reuters</source></item><item><title>New blood test detects colon cancer before it develops</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239818131&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:14:00</pubDate><description>Highly sensitive and accurate test detects cancer-related microRNA in blood of patients even before the development of colorectal cancer   DALLAS, June 19, 2013 /PRNewswire-USNewswire/ --? A new blood </description><source>I Stock Analyst</source></item><item><title>Toronto doc unveils 'sharpshooter' cancer drug</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239827854&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:08:00</pubDate><description>A renowned Toronto researcher and a U.S. colleague have unveiled a new "sharpshooter" drug that they say could provide a breakthrough in inhibiting the growth of a variety of cancers. Dr. Tak Mak, an </description><source>Woodstock Sentinel-Review</source></item><item><title>DiaTech Oncology Test Shows Positive Results, Identifies New Therapeutic Strategies </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239837170&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T11:55:00</pubDate><description>NASHVILLE, Tenn.--(BUSINESS WIRE)-- DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville, Tenn., has developed a predictive test that has been effective in clinical </description><source>CNBC</source></item><item><title>Research and Markets: Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239823103&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:42:00</pubDate><description>Research and Markets (http://www.researchandmarkets.com/research/32pl34/triple_analysis) has announced the addition of the "Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines" report to their </description><source>Reuters</source></item><item><title>Talcum Powder Linked to Ovarian Cancer!</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239770814&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:41:00</pubDate><description>A new research has suggested women regularly using talcum powder to keep fresh actually increase their risk of developing ovarian cancer by almost a quarter. Scientists have warned powder particles applied </description><source>Indiatimes</source></item><item><title>Castle Biosciences Announces Availability of Esophageal Cancer Test Designed to </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239841806&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:31:00</pubDate><description>Test Provides Personalized Information for More Informed Treatment Planning Educational Website Launched   PR Newswire  FRIENDSWOOD, Texas, June 19, 2013 FRIENDSWOOD, Texas, June 19, 2013 /PRNewswire/ </description><source>Reuters</source></item><item><title>Research and Markets: Metastatic Liver Cancer - Pipeline Review, H1 2013</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239833133&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:32:00</pubDate><description>Research and Markets (http://www.researchandmarkets.com/research/qhqtzd/metastatic_liver) has announced the addition of the "Metastatic Liver Cancer - Pipeline Review, H1 2013" report to their offering. </description><source>Reuters</source></item><item><title>Research and Markets: Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239838822&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T11:47:00</pubDate><description>Research and Markets (http://www.researchandmarkets.com/research/n5dk2k/triple_analysis) has announced the addition of the "Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies" report to their </description><source>Reuters</source></item><item><title>Brazil to produce H1N1 flu vaccine</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239794819&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:24:00</pubDate><description>terrorism in avian flu cases: Intelligence Bird flu outbreak threatens Lampung Rio de Janeiro (ANTARA News/Xinhua-OANA) - Brazil plans to produce vaccines against the influenza H1N1 virus, Health Minister </description><source>Antara News</source></item><item><title>Sunshine Biopharma's Anticancer Drug Candidate, Adva-27a, Is Unaffected by the Recent </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239839991&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:18:00</pubDate><description>- Sunshine Biopharma Inc. (OTCQB   "Sunshine Biopharma is not in the business of patenting human genes or copies thereof, such as cDNA.? We patent small molecules for use as chemotherapeutics in the treatment </description><source>Yahoo! Finance</source></item><item><title>Canadian-U.S. team of researchers has developed a new 'sharp-shooter' drug they </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239840608&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:04:00</pubDate><description>A team of Canadian and U.S. researchers has developed a new "sharp-shooter" drug they hope may be a breakthrough in treating several types of aggressive cancer.  The drug, known for now as CFI-400945, </description><source>CBC</source></item><item><title>Research and Markets: Triple Analysis: Lymphoma, Apoptosis and Cancer Vaccines Report</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239837180&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T11:46:00</pubDate><description>DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/rhmxtn/triple_analysis) has announced the addition of the report to their offering.   This triple analysis focuses </description><source>CNBC</source></item><item><title>Can you hear the shape of a room?</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239700874&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T01:52:00</pubDate><description>_ Imagine yourself blindfolded and placed in a strange room; you snap your fingers or click your tongue, and listen closely to the echoes. Can you hear the shape of the room? Does the sound tell you if </description><source>Chicago Tribune</source></item><item><title>Research and Markets: Triple Analysis: Lymphoma, Pancreatic Cancer and Cancer Vaccines</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239835335&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:55:00</pubDate><description>DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/vx43jc/triple_analysis) has announced the addition of the report to their offering. This triple analysis focuses </description><source>Yahoo! Finance</source></item><item><title>Research and Markets: Triple Analysis: Angiogenesis, Cancer Vaccines and Protein </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239843784&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:18:00</pubDate><description>DUBLIN--(BUSINESS WIRE)--   Research and Markets (http://www.researchandmarkets.com/research/ff59xb/triple_analysis) has announced the addition of the report to their offering.   This triple analysis </description><source>Yahoo! Finance</source></item><item><title>Curie-Cancer and Sanofi cooperate in research on ovarian cancer</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239826901&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T11:47:00</pubDate><description>Sanofi (EURONEXT: SAN and NYSE: SNY) and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, announce today the establishment of a three-year research collaboration </description><source>European Pharmaceutical Review</source></item><item><title>BRIEF: Modesto superintendent surprises former grad in Las Vegas with diploma</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239825141&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:50:00</pubDate><description>(The Modesto Bee - McClatchy-Tribune Information Services via COMTEX) -- Aaron Felish, a 2005 Modesto High grad, met with Modesto City Schools Superintendent Pam Able in Las Vegas this month after she </description><source>TMC Net</source></item><item><title>Cancer prevention study kicks off</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239841087&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:07:00</pubDate><description>"Now is the time to commit," Carla Hakes emphasized last week.  She was referring to volunteers willing to participate in the American Cancer Society's CPS-3 that will kick-off at the Relay for Life of </description><source>Mille Lacs Messenger</source></item><item><title>The Overlooked Potential Value of the Nuvilex Therapy</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239847932&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T12:40:00</pubDate><description>The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, believes investors might be overlooking the potential value of Nuvilex's (OTCQB: NVLX) unique </description><source>Individual.com</source></item><item><title>Secondary primary cancer in patients with head and neck carcinoma: the differences </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239835014&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:53:00</pubDate><description>This paper presents a population-based retrospective cohort study to identify the differences in secondary primary cancer (SPC) among hypopharyngeal, laryngeal, and other sites of head and neck cancer </description><source>European Journal of Cancer Care</source></item><item><title>Polyp growth identifies colorectal cancer</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239819397&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:24:00</pubDate><description>medwireNews: Monitoring colorectal polyp growth with computed tomography (CT) could help target treatment in patients undergoing routine colorectal cancer surveillance, research suggests.  CT results </description><source>MedWire News</source></item><item><title>Advinus Therapeutics and Moffitt Cancer Centre ink strategic pact for cancer drug </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239734250&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:55:00</pubDate><description>Advinus Therapeutics and Moffitt Cancer Centre have entered into a strategic partnership to advance its discoveries to the clinics. The former has launched a Special Purpose Vehicle incorporated as a </description><source>PharmaBiz</source></item><item><title>Aurigene and Debiopharm GroupT Report Nomination of Development Candidate Debio </title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239819087&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T10:26:00</pubDate><description>SOURCE The Debiopharm Group  LAUSANNE   Aurigene Discovery Technologies, a Bangalore Debio? 0617B is a novel small molecule targeting an undisclosed oncology pathway which has started IND enabling studies, </description><source>KEYC Television</source></item><item><title>'Undruggable' To Druggable: A New Target For Cancer Drug Development</title><link>http://www.congoo.com/news/addstorycomment.aspx?st=239652898&amp;Channel_ID=69&amp;Category_ID=262</link><pubDate>2013-06-19T09:23:00</pubDate><description>Harvard Stem Cell Institute (HSCI) researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug </description><source>Medical News Today</source></item></channel></rss>